Cargando…
Targeted Screening for Chronic Q Fever, the Netherlands
Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices locate...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239892/ https://www.ncbi.nlm.nih.gov/pubmed/35731163 http://dx.doi.org/10.3201/eid2807.212273 |
_version_ | 1784737412864278528 |
---|---|
author | Reukers, Daphne F.M. de Boer, Pieter T. Loohuis, Alfons O. Wever, Peter C. Bleeker-Rovers, Chantal P. van Gageldonk-Lafeber, Arianne B. van der Hoek, Wim Timen, Aura |
author_facet | Reukers, Daphne F.M. de Boer, Pieter T. Loohuis, Alfons O. Wever, Peter C. Bleeker-Rovers, Chantal P. van Gageldonk-Lafeber, Arianne B. van der Hoek, Wim Timen, Aura |
author_sort | Reukers, Daphne F.M. |
collection | PubMed |
description | Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices located in outbreak areas selected 3,419 patients who had specific underlying medical conditions, of whom 1,642 (48%) participated. Immunofluorescence assay of serum showed that 289 (18%) of 1,642 participants had a previous Coxiella burnetii infection (IgG II titer >1:64), and 9 patients were suspected of having chronic Q fever (IgG I y titer >1:512). After medical evaluation, 4 of those patients received a chronic Q fever diagnosis. The cost of screening was higher than estimated earlier, but the program was still cost-effective in certain high risk groups. Years after a large Q fever outbreak, targeted screening still detected patients with chronic Q fever and is estimated to be cost-effective. |
format | Online Article Text |
id | pubmed-9239892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Centers for Disease Control and Prevention |
record_format | MEDLINE/PubMed |
spelling | pubmed-92398922022-07-06 Targeted Screening for Chronic Q Fever, the Netherlands Reukers, Daphne F.M. de Boer, Pieter T. Loohuis, Alfons O. Wever, Peter C. Bleeker-Rovers, Chantal P. van Gageldonk-Lafeber, Arianne B. van der Hoek, Wim Timen, Aura Emerg Infect Dis Research Early detection of and treatment for chronic Q fever might prevent potentially life-threatening complications. We performed a chronic Q fever screening program in general practitioner practices in the Netherlands 10 years after a large Q fever outbreak. Thirteen general practitioner practices located in outbreak areas selected 3,419 patients who had specific underlying medical conditions, of whom 1,642 (48%) participated. Immunofluorescence assay of serum showed that 289 (18%) of 1,642 participants had a previous Coxiella burnetii infection (IgG II titer >1:64), and 9 patients were suspected of having chronic Q fever (IgG I y titer >1:512). After medical evaluation, 4 of those patients received a chronic Q fever diagnosis. The cost of screening was higher than estimated earlier, but the program was still cost-effective in certain high risk groups. Years after a large Q fever outbreak, targeted screening still detected patients with chronic Q fever and is estimated to be cost-effective. Centers for Disease Control and Prevention 2022-07 /pmc/articles/PMC9239892/ /pubmed/35731163 http://dx.doi.org/10.3201/eid2807.212273 Text en https://creativecommons.org/licenses/by/4.0/Emerging Infectious Diseases is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited. |
spellingShingle | Research Reukers, Daphne F.M. de Boer, Pieter T. Loohuis, Alfons O. Wever, Peter C. Bleeker-Rovers, Chantal P. van Gageldonk-Lafeber, Arianne B. van der Hoek, Wim Timen, Aura Targeted Screening for Chronic Q Fever, the Netherlands |
title | Targeted Screening for Chronic Q Fever, the Netherlands |
title_full | Targeted Screening for Chronic Q Fever, the Netherlands |
title_fullStr | Targeted Screening for Chronic Q Fever, the Netherlands |
title_full_unstemmed | Targeted Screening for Chronic Q Fever, the Netherlands |
title_short | Targeted Screening for Chronic Q Fever, the Netherlands |
title_sort | targeted screening for chronic q fever, the netherlands |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239892/ https://www.ncbi.nlm.nih.gov/pubmed/35731163 http://dx.doi.org/10.3201/eid2807.212273 |
work_keys_str_mv | AT reukersdaphnefm targetedscreeningforchronicqfeverthenetherlands AT deboerpietert targetedscreeningforchronicqfeverthenetherlands AT loohuisalfonso targetedscreeningforchronicqfeverthenetherlands AT weverpeterc targetedscreeningforchronicqfeverthenetherlands AT bleekerroverschantalp targetedscreeningforchronicqfeverthenetherlands AT vangageldonklafeberarianneb targetedscreeningforchronicqfeverthenetherlands AT vanderhoekwim targetedscreeningforchronicqfeverthenetherlands AT timenaura targetedscreeningforchronicqfeverthenetherlands |